Denise Mann

No two people in the world have the same color eyes. Experts weigh in on the genetics that cause the rarest eye color in the world...plus, what can cause our eye color to change.

Research suggests that telltale symptoms may appear before cardiac arrest, and knowing how to recognize them can be lifesaving.

A timely diagnostic workup is warranted in adults with suspected atopic dermatitis (AD) who fail to respond to optimized, guideline-recommended care, with clinical expertise guiding the selection of appropriate tests. This is the main message from a new Good Practice Statement on the diagnostic workup of adults with presumed AD unresponsive to therapy in the […]

Some people with chronic cutaneous lupus erythematosus may be less likely to acquire life-threatening infections when taking the drug anifrolumab (Saphnelo, AstraZeneca). Published in the Journal of the European Academy of Dermatology and Venereology (JEADV), the findings highlight how anifrolumab can provide distinct benefits over the use of conventional immunosuppressants in patients with treatment-resistant chronic […]

By Denise Mann Shutterstock Add Health Digest on Google: We may receive a commission on purchases made from links.

Fibromyalgia often causes anxiety, depression, and trouble sleeping. Migraines and restless leg syndrome also frequently co-occur.

Robert R. Redfield, MD, is the new Chief Scientific Officer of Turn Therapeutics, Inc. Dr. Redfield served as the 18th Director of the US Centers for Disease Control and Prevention. He previously held senior scientific and clinical leadership positions at the University of Maryland School of Medicine in Baltimore, MD, where he was Professor of […]

EltaMD Skin Care is launching “No Offseason for SPF,” a new campaign designed to disrupt the well-known seasonal decline in sunscreen use. To bring the “No Offseason for SPF” campaign to life, EltaMD will be partnering with Kristin Juszczyk, Founder and Chief Creative Officer of Off Season, in addition to her makeup artist, Hailey Hoff. “My work has […]

The first healthy volunteers have been dosed in the Phase 1 study of Bionyra Pharma’s BYN-001, a long-acting anti-interleukin (IL)-25 monoclonal antibody being developed for atopic dermatitis (AD). The study, designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamic profile of BYN-001 in healthy volunteers, has been initiated in Australia, with the first cohort of […]

Tanmaxxing is on trend, but off the mark, and it can increase risks of both visible and beneath-the- surface skin damage, explains Vishal Anil Patel, MD, FASDS, FACMS, an Associate Professor of Dermatology and Associate Professor of Medicine/Oncology at the George Washington University School of Medicine & Health Sciences, the Director of Cutaneous Oncology at […]